Clinical trials

8

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Irreversible Electroporation (IRE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) in Men With Benign Prostatic Hyperplasia (BPH)

This study will evaluate the safety and effectiveness of using Irreversible Electroporation (IRE) for the treatment of symptomatic benign prostatic hyperplasia (BPH).

Participants needed: 40
Trial details
Age: 50+Biological sex: MaleType: InterventionalSponsor: Angiodynamics, Inc.Updated: Jun 11, 2026
Eligibility criteria

Male, age ≥50 years. [+8]

Patients with ≥ Grade Group 2 prostate cancer (≥ Gleason score 7). [+19]

Status: Recruiting

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness

The investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.

Participants needed: 39
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: May 11, 2026Locations: 6
Eligibility criteria

Provision of signed and dated informed consent form. [+7]

Subjects who are or may be pregnant as determined by a positive pregnancy test o... [+21]

Status: Not yet recruiting

Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis

The investigation aims to demonstrate initial safety and efficacy of the AngioVac System for the removal of vegetation in the right heart in patients with infective endocarditis.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: Apr 22, 2026
Eligibility criteria

Subject age ≥ 18 years [+4]

Subject requires debulking of vegetation on cardiac leads [+12]

Status: Not yet recruiting

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is treatment with Auryon Atherectomy System more effective than angioplasty alone in preventing death, amputation, revascularization and improving patency? Researchers will compare the Auryon Atherectomy System with balloon angioplasty to balloon angioplasty alone.

Participants needed: 50
Trial details
Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: Mar 16, 2026
Eligibility criteria

Age of subject is ≥ 18. [+12]

Target lesion is in a vessel graft or synthetic graft. [+26]

Status: Recruiting

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is treatment with Auryon Atherectomy System more effective than angioplasty alone in preventing death, amputation, revascularization and improving patency? Researchers will compare the Auryon Atherectomy System with balloon angioplasty to balloon angioplasty alone.

Participants needed: 224
Trial details
Phase: Phase 4Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: Jan 8, 2026Locations: 9
Eligibility criteria

Age of subject is ≥ 18. [+12]

Target lesion is in a vessel graft or synthetic graft. [+26]

Status: Not yet recruiting

International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE

Procedural data will be recorded from patients with liver metastases from colorectal cancer who have received at least one course of systemic chemotherapy and who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: Oct 10, 2025Locations: 1
Eligibility criteria

Patients aged 18 years and over, able to provide informed consent and with histo... [+9]

Patients involved in other research studies. [+12]

Status: Not yet recruiting

International Study on Treatment of Liver (HCC) Patients With IRE

Procedural data will be recorded from patients with liver lesions from hepatocellular cancer who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: Oct 10, 2025Locations: 1
Eligibility criteria

Patients aged 18 years and over, able to provide informed consent and with clini... [+7]

Patients involved in other research studies. [+17]

Status: Recruiting

Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

To evaluate the efficacy, safety, and long-term functional outcomes of percutaneous mechanical aspiration thrombectomy using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System for the treatment of acute pulmonary embolism.

Participants needed: 256
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Angiodynamics, Inc.Updated: Sep 26, 2025Locations: 1
Eligibility criteria

Symptomatic, CTPA-proven acute PE with a maximum duration of symptoms of 14 days... [+8]

A contraindication to therapeutic anticoagulation [+14]